Placental Site Trophoblastic Tumor Medication Savings with TheDrugClub
Discount pricing may be available. Current formulary eligibility is being verified; a condition association does not establish FREE coverage.
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
About Placental Site Trophoblastic Tumor
Placental Site Trophoblastic Tumor (PSTT) is a rare form of gestational trophoblastic neoplasia that develops after pregnancy, often requiring specialized and sometimes expensive treatments. At TheDrugClub, we understand the financial burden these conditions can place on families. Our membership program is designed to help you save on the vital medications needed for managing PSTT, ensuring care is more accessible.
Placental Site Trophoblastic Tumor (PSTT) is a very rare and distinct type of gestational trophoblastic neoplasia (GTN), a group of conditions that originate from the cells that form the placenta during pregnancy. Unlike other GTNs, PSTT arises from intermediate trophoblasts, cells that normally anchor the placenta to the uterine wall. It can occur months or even years after any type of pregnancy, including full-term births, miscarriages, or abortions. While often slow-growing, PSTT has the potential to spread (metastasize) if not detected and treated early. Symptoms can be subtle, such as irregular vaginal bleeding or amenorrhea, making diagnosis challenging.
Treatment for PSTT largely depends on the stage of the disease,
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.